![Kristin Woolley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Kristin Woolley
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Abingworth LLP
![]() Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022.
2
| Subsidiary | Investment Managers | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kristin Woolley tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Golub Capital Partners LLC
![]() Golub Capital Partners LLC Investment ManagersFinance Golub Capital Partners LLC (Golub Capital Partners) is a private equity firm founded in 1994 by Lawrence Eric Golub. The firm is headquartered in Chicago, Illinois. | Investment Managers | Private Equity Investor | |
SOLENO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
HSBC Global Markets Select Funds Plc | Investment Trusts/Mutual Funds | Director/Board Member | |
Abingworth Management Ltd.
![]() Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
Abingworth Bioventures VI LP
![]() Abingworth Bioventures VI LP Investment ManagersFinance Abingworth Bioventures VI LP invests in private and public companies located the US and Europe. The fund targets companies operating in the fields of medical devices, instrumentation, bio therapeutics, small molecules, nucleic acid therapeutics, vaccines, specialty pharma, technologies, diagnostics and software. The fund provides financing for seed, early and late stage capital requirements with an investment size of $15 - $30 million. It seeks Majority or minority investments in the companies. | Investment Managers | Director/Board Member | |
Institute of Chartered Accountants in England & Wales
![]() Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Credit Suisse Securities (Europe) Ltd.
![]() Credit Suisse Securities (Europe) Ltd. Investment Banks/BrokersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Investment Banks/Brokers | Analyst-Equity | |
Northwestern University
![]() Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
JPMorgan Worldwide Securities Services
![]() JPMorgan Worldwide Securities Services Investment Banks/BrokersFinance JPMorgan Worldwide Securities Services engages in the provision of security brokerage services. The company is headquartered in New York, NY. | Investment Banks/Brokers | Corporate Officer/Principal | |
HSBC Bank Plc (Broker)
![]() HSBC Bank Plc (Broker) Investment Banks/BrokersFinance HSBC Bank Plc (Broker) (HSBC Bank-Broker) is the broker/dealer division of HSBC Bank Plc, which is owned by HSBC Holdings Plc (LON: HSBA; NYSE: HSBC) in Great Britain. Headquartered in London, HSBC Bank-Broker was founded in 1880 and offers bespoke brokerage services across every major asset class for their corporate and institutional clients. | Investment Banks/Brokers | Analyst-Equity | |
VERONA PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
King's College London | College/University | Undergraduate Degree | |
Deerpath Capital Management LP
![]() Deerpath Capital Management LP Investment ManagersFinance Deerpath Capital Management LP (Deerpath Capital Management) is a private equity firm founded by Gary C. Wendt, James Kirby and John Fitzgibbons in 2007. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
The Wharton Health Care Alumni Association | Director/Board Member | ||
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
ADICET BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Locki Therapeutics Ltd.
![]() Locki Therapeutics Ltd. BiotechnologyHealth Technology Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases. | Biotechnology | Director/Board Member | |
Entact Bio, Inc.
![]() Entact Bio, Inc. BiotechnologyHealth Technology Entact Bio, Inc. is a company that focuses on creating new medicines by enhancing protein function. The company is based in Watertown, MA. The company is a team of scientists, entrepreneurs, drug creators, and problem solvers who work together to bring new medicines to patients who currently have few options. The CEO of the company is Victoria M. Richon. The founder of the company grew up in chaos and instability in an undisclosed capital city and has always been passionate and motivated to help enhance and provide medical solutions. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Regno Unito | 9 |
Irlanda | 2 |
Settori
Finance | 8 |
Health Technology | 7 |
Consumer Services | 4 |
Miscellaneous | 2 |
Commercial Services | 2 |
Posizioni
Director/Board Member | 9 |
Independent Dir/Board Member | 4 |
Corporate Officer/Principal | 3 |
Analyst-Equity | 2 |
Private Equity Analyst | 2 |
Contatti più connessi
Insiders | |
---|---|
Andrew Sinclair | 14 |
Reed Van Gorden | 7 |
- Borsa valori
- Insiders
- Kristin Woolley
- Connessioni Società